At the 2026 NCCN Annual Meeting, CURE sat down with Dr. Thomas Flaig to discuss the rapidly evolving landscape of bladder ...
As new therapies emerge, particularly for non-muscle invasive disease, clinicians and patients are faced with increasingly ...
A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...
Nearly 200,000 Americans are living with muscle-invasive bladder cancer (MIBC), a severe and fast-growing type of bladder cancer that penetrates the thick muscle layer of the bladder wall. After ...
TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results